bedaquiline and glyoxylic-acid

bedaquiline has been researched along with glyoxylic-acid* in 1 studies

Other Studies

1 other study(ies) available for bedaquiline and glyoxylic-acid

Article	Year
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis. Nature communications, 2020, 11-30, Volume: 11, Issue:1 The approval of bedaquiline (BDQ) for the treatment of tuberculosis has generated substantial interest in inhibiting energy metabolism as a therapeutic paradigm. However, it is not known precisely how BDQ triggers cell death in Mycobacterium tuberculosis (Mtb). Using Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Carbon Cycle; Citric Acid Cycle; Diarylquinolines; Energy Metabolism; Glycolysis; Glyoxylates; Mycobacterium tuberculosis; Oxidative Phosphorylation; Tuberculosis	2020

Article

Year

Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis.

Nature communications, 2020, 11-30, Volume: 11, Issue:1

The approval of bedaquiline (BDQ) for the treatment of tuberculosis has generated substantial interest in inhibiting energy metabolism as a therapeutic paradigm. However, it is not known precisely how BDQ triggers cell death in Mycobacterium tuberculosis (Mtb). Using

Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Carbon Cycle; Citric Acid Cycle; Diarylquinolines; Energy Metabolism; Glycolysis; Glyoxylates; Mycobacterium tuberculosis; Oxidative Phosphorylation; Tuberculosis

2020